Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

ZCAN262

ZCAN262 (compound 6) is an AMPA modulator. ZCAN262 prevents AMPA-mediated excitotoxicity by targeting an allosteric binding site[1].

Product Specifications

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

IGluR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/zcan262.html

Purity

99.93

Solubility

DMSO : 100 mg/mL (ultrasonic; warming; heat to 80°C)

Smiles

CN(C(C1=NC(N2CC3=CN(N=C3C2)CC4=CC=C(C=C4F)F)=NC=C1)=O)C

Molecular Formula

C19H18F2N6O

Molecular Weight

384.38

Precautions

H302, H315, H319, H335

References & Citations

[1]Dongxu Zhai, et al. Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis. Sci Adv. 2023, 9, 49.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

AMPA Receptor

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Retinoblastoma discontinued
404098-01 50 µL

Retinoblastoma discontinued

Ask
View Details
Retinoblastoma discontinued
404098-02 100 µL

Retinoblastoma discontinued

Ask
View Details
BHLHE22 Antibody
R36464-100UG 100 µg

BHLHE22 Antibody

Ask
View Details
DUSP9, CT (DUSP9, MKP4, Dual specificity protein phosphatase 9, Mitogen-activated protein kinase phosphatase 4) (Azide free) (HRP) discontinued
034862-HRP 200 µL

DUSP9, CT (DUSP9, MKP4, Dual specificity protein phosphatase 9, Mitogen-activated protein kinase phosphatase 4) (Azide free) (HRP) discontinued

Ask
View Details
Mitumomab
abx831759-01 100 µg

Mitumomab

Ask
View Details
Mitumomab
abx831759-02 1 mg

Mitumomab

Ask
View Details